No Data
No Data
Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting
Express News | Kura Oncology Announces Preclinical Data for Ko-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting
Express News | Kura Oncology Grants 190,000 Stock Options To Six New Employees As Inducement Awards
Press Release: Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kura Oncology Price Target Cut to $14.00/Share From $27.00 by UBS
UBS Maintains Kura Oncology(KURA.US) With Buy Rating, Cuts Target Price to $14